Email this article MOLECULAR-GENETIC CHARACTERISTICS OF PARVOVIRUS B19 ISOLATES CIRCULATING IN THE NORTH-WESTERN FEDERAL DISTRICT
- Authors: Khamitova I.V.1, Ostankova Y.V.1, Antipova A.Y.1, Semenov A.V.2, Lavrentieva I.N.1
-
Affiliations:
- Pasteur Research Institute of Epidemiology and Microbiology
- Pasteur Research Institute of Epidemiology and Microbiology, Pavlov State Medical University, Mechnikov North-West State Medical University
- Issue: Vol 95, No 6 (2018)
- Pages: 55-61
- Section: Articles
- Submitted: 10.04.2019
- Published: 28.12.2018
- URL: https://microbiol.crie.ru/jour/article/view/329
- DOI: https://doi.org/10.36233/0372-9311-2018-6-55-61
- ID: 329
Cite item
Full Text
Abstract
Aim. Genotyping and molecular genetic characteristics of parvovirus B19, circulating in the NorthWest Federal District. Material and Methods. The material of the study is based on serum samples from 821 patients with maculopapular rash negative for antibodies IgM-measles and IgM-rubella were received at the St. Petersburg Regional Center for Measles and Rubella Surveillance in 2009-2017. In the present study we used genotyping by direct sequencing of the NS1/VP1 region of Parvovirus B19 genome. Results. DNA of the virus was detected in 59 (42.4%) of seropositive patients. To assess the heterogeneity of isolates, 14 samples were selected from patients from geographically remote regions of the NWFO, of different ages, regardless of gender, with a high viral load (106-107 copies/ml). Based on the phylogenetic analysis of the isolates showed that only the genotype 1A was detected in all isolates. The nucleotide sequences can be divided into two subgroups: 13 isolates (92.8%) belong to the subgroup 1A2, one isolate to the subgroup 1A1. Conclusion. The introduction of B19 screening from patients with fever / rash can provide meaningful information on the prevalence of parvovirus infection in the Russian Federation. Identifying new mutations of the virus and further analysis of their possible relationships with the course of the mutation disease can help in the development of medicines, as well as in the development of an effective vaccine against the parvovirus B19.
Keywords
About the authors
I. V. Khamitova
Pasteur Research Institute of Epidemiology and Microbiology
Author for correspondence.
Email: noemail@neicon.ru
Россия
Yu. V. Ostankova
Pasteur Research Institute of Epidemiology and Microbiology
Email: noemail@neicon.ru
Россия
A. Yu. Antipova
Pasteur Research Institute of Epidemiology and Microbiology
Email: noemail@neicon.ru
Россия
A. V. Semenov
Pasteur Research Institute of Epidemiology and Microbiology, Pavlov State Medical University, Mechnikov North-West State Medical University
Email: noemail@neicon.ru
Россия
I. N. Lavrentieva
Pasteur Research Institute of Epidemiology and Microbiology
Email: noemail@neicon.ru
Россия
References
- Broliden K., Tolfvenstam T., Norbeck O. Clinical aspects of parvovirus B19 infection. J. Intern. Med. 2006, 260(4): 285-304.
- Candotti D., Etiz N., Parsyan A. et al. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J. Virol. 2004, 78: 2169-12178.
- Cohen B.J., Gandhi J., Clewley J.P. Genetic variants of parvovirus B19 identified in the United Kingdom: implications for diagnostic testing. J. Clin. Virol. 2006, 36(2): 152-155.
- Duffy S., Shackelton L.A., Holmes E.C. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet. 2008, 9: 267-276.
- Gallinella G., Venturoli S., Manaresi E. et al. B19 virus genome diversity: epidemiological and clinical correlations. J. Clin. Virol. 2003, 28(1):1-13.
- Hubschen J.M., Mihneva Z., Mentis A.F. et al. Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J. Clin. Microbiol. 2009, 47(11): 3735-3738.
- Kuhl U., Lassner D., Pauschinger M. et al. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J. Med. Virol. 2008, 80(7):1243-1251.
- Kumar S., Stecher G., Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Molecular Biology and Evolution. 2016, 33(7):1870-1874.
- Molenaar-de Backer M.W., Lukashov V.V., van Binnendijk R.S. et al. Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions. PLoS One. 2012, 7(8): e43206.
- Norja P., Hokynar K., Aaltonen L.M. et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc. Natl. Acad. Sci. USA. 2006, 103(19):7450-7453.
- Sanabani S., Neto W. K., Pereira J. et al. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J. Clin. Microbiol. 2006, 44: 604-606.
- Servant A., Laperche S., Lallemand F. et al. Genetic diversity within human erythroviruses: identification of three genotypes. J. Virol. 2002, 76: 9124-9134.
- Shackelton L.A., Holmes E.C. Phylogenetic evidence for the rapid evolution of human B19 erythrovirus. J. Virol. 2006, 806: 3666-3669.
- Suzuki M., Yoto Y., Ishikawa A. et al. Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008. J. Virol. 2009, 83:10975-10980.
- Toan N.L., Duechting A., Kremsner P.G. et al. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J. Gen. Virol. 2006, 87: 2941-2949.
Supplementary files
